Thyrocare Technologies Ltd
NSE: THYROCARE BSE: 539871
₹495.50
+12.60 (2.61%)
Sun, 08 Nov 2026, 05:54 am
Market Cap (in Cr)7678.93
PE Ratio55.42
Dividend1.93
Health Services
Medical/Nursing Services
24.5KThyrocare Technologies Ltd Company History
2000
- The Company was incorporated as Thyrocare Technologies Limited.
- The Company received a certificate of commencement of business from the RoC.
2001
- The Company received ISO 9001 certification.
- The Company commenced commercial operations under the brand name 'Thyrocare'.
2005
- The Company received NABL accreditation.
2006
- The Company issued certain fully convertible debentures aggregating to 250 million to BCCL.
2007
- The Company receives accreditation from the College of American Pathologists (CAP).
2010
- The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia.
- Agalia also acquired certain Equity Shares aggregating to 1,250 million from the Promoters and certain other persons.
- The Company launched wellness packages under the brand name 'Aarogyam'.
2011
- The Company migrated to 'total laboratory automation system' installed by Siemens for efficient handling of increasing volumes.
2012
- NVP acquired certain Equity Shares aggregating to 1,200 million from certain entities.
2013
- EIF acquired certain Equity Shares from Agalia.
- The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1,000 scans in the first year of operation.
2014
- The Company had installed, India’s first and the world’s longest track automation system for seamless sample movements from Siemens Limited.
- The Company commissioned the operations in medical cyclotron facility in Navi Mumbai.
- The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations.
2015
- The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily.
- The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name 'WHATERS'.
- The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception.
2016
- Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities.
2024
- Thyrocare Technologies Completed acquisition of Think Health Diagnostic Private Limited.
